Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDELALISIB vs IMBRUVICA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDELALISIB vs IMBRUVICA: Safety Overview

Metric IDELALISIB IMBRUVICA
Total FAERS Reports 6,862 242
Deaths Reported 1,548 74
Death Rate 22.6% 30.6%
Hospitalizations 2,962 125
Average Patient Age 70.0 yrs 72.1 yrs
% Female Patients 38.4% N/A
FDA Approval Date Jul 23, 2014 N/A
Manufacturer Gilead Sciences, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A